As a substantial minority of individuals with commonforms of obesity, not associated with leptin mutations, have relatively low levelsof circulating leptin63, augmenting leptin levels in this subgroupcould be therapeutically worthwhile. This evidence concerns the gene LEP and obesity disorder.